Aimee Coscarart, MD
Dermatology · Hammond, LANPI 1699195958
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,425 of the $14,935 with a category attached, or 63.1%. E.r. Squibb & Sons, L.L.C. accounts for 72.8% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $13,291, more than ten times the $125 reported in 2021.
Across 200 payments — averaging $74.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$11K
- AbbVie$1K
- Johnson & Johnson$477
- Sanofi$414
- Hill Dermaceuticals, Inc.$352
- Regeneron Healthcare Solutions, Inc.$324
- plus $1K from 12 others
What the payments were for
- Consulting fees$9,42563%
- Travel & lodging$1,0887%
- Food & beverage$4,11128%
- Education$3112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 19 | $10,873 |
| AbbVie | 61 | $1,026 |
| Johnson & Johnson | 17 | $477 |
| Sanofi | 14 | $414 |
| Hill Dermaceuticals, Inc. | 1 | $352 |
| Regeneron Healthcare Solutions, Inc. | 13 | $324 |
| Pfizer | 16 | $309 |
| LEO Pharma Inc. | 16 | $304 |
| UCB, Inc. | 8 | $195 |
| Galderma Laboratories, L.p. | 15 | $171 |
| Lilly USA, LLC | 7 | $153 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Novartis | 4 | $88 |
| Incyte Corporation | 2 | $45 |
| Sun Pharmaceutical Industries Inc. | 2 | $35 |
| Journey Medical Corporation | 1 | $27 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $21 |
| Organon | 2 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,935 in reported general payments places this provider in the 80th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 23 | $1,001 |
| Ketoconazole | 58 | $872 |
| Finasteride | 98 | $827 |
| Doxycycline Hyclate | 35 | $724 |
| Mometasone Furoate | 31 | $587 |
| Spironolactone | 21 | $324 |
| Clindamycin Phosphate | 13 | $311 |
| Triamcinolone Acetonide | 20 | $139 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hammond
- Rebecca SoineHammond$12K
- Haley HuntHammond$9K
- Katherine HolcombMetairie$411K
- William ClaiborneNew Orleans$374K
- Blair BuddenLafayette$329K
- Erin BohNew Orleans$277K
- Mara HaseltineNew Orleans$276K
- Sarah HaydelHouma$265K
- Frankie RholdonLafayette$227K
- William MassengalePrairieville$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.